Public Health Principal Secretary Mary Muthoni/HANDOUTThe Principal Secretary for Public Health, Mary Muthoni, has assured Kenyans that there are enough drugs to treat malaria, HIV, and ...

A University of Colorado professor who experienced a funding freeze firsthand this year expressed relief at the program's ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...

Kenya is set to introduce a revolutionary injectable HIV prevention drug, Lenacapavir, becoming one of nine African nations ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

Kenya is among nine African countries, under the low- and middle-income category, that are set to be among the early beneficiaries of lenacapavir, a long-acting HIV prevention drug, following a recent ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...